KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $2.9 billion.

  • Boston Scientific's Operating Expenses rose 1793.39% to $2.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $10.2 billion, marking a year-over-year increase of 1523.57%. This contributed to the annual value of $10.2 billion for FY2025, which is 1523.57% up from last year.
  • According to the latest figures from Q4 2025, Boston Scientific's Operating Expenses is $2.9 billion, which was up 1793.39% from $2.5 billion recorded in Q3 2025.
  • Over the past 5 years, Boston Scientific's Operating Expenses peaked at $2.9 billion during Q4 2025, and registered a low of $1.5 billion during Q1 2021.
  • Over the past 5 years, Boston Scientific's median Operating Expenses value was $2.0 billion (recorded in 2021), while the average stood at $2.0 billion.
  • Examining YoY changes over the last 5 years, Boston Scientific's Operating Expenses showed a top increase of 4575.21% in 2021 and a maximum decrease of 1754.39% in 2021.
  • Quarter analysis of 5 years shows Boston Scientific's Operating Expenses stood at $2.0 billion in 2021, then dropped by 7.34% to $1.8 billion in 2022, then grew by 9.02% to $2.0 billion in 2023, then increased by 21.3% to $2.4 billion in 2024, then increased by 17.93% to $2.9 billion in 2025.
  • Its Operating Expenses stands at $2.9 billion for Q4 2025, versus $2.5 billion for Q3 2025 and $2.6 billion for Q2 2025.